Grifols Therapeutics, Inc.
Research ServicesNorth Carolina, United States11-50 Employees
Grifols Therapeutics, Inc. is a research company based out of 79 TW ALEXANDER DR 4101 RESEARCH COMMONS, Research Triangle Park, North Carolina, United States.
Niche Research Focus Grifols Therapeutics operates within the specialized research services industry, presenting opportunities to offer tailored research tools, data analytics, or partnerships that enhance their research capabilities.
Middle-Market Potential With annual revenues between 25 million and 50 million and a relatively small team, the company is positioned for scalable solutions that support growth in research infrastructure or process optimization.
Location Advantage Based in Durham, North Carolina, near Research Triangle Park, the company is in a hub of innovation and life sciences, offering opportunities for collaboration with other biotech or research firms.
Growth Opportunities As a smaller company in a competitive landscape, Grifols could be receptive to innovative technology integrations, such as advanced lab management platforms or secure data sharing systems.
Strategic Partnerships Potential to establish strategic alliances with larger pharma companies or research organizations in the region, leveraging their focus on research services to expand service offerings or co-develop solutions.
| Grifols Therapeutics, Inc. Email Formats | Percentage |
| First.Last@grifols.com | 90% |
| FirstL@grifols.com | 4% |
| First.Middle@grifols.com | 3% |
| Last.F@grifols.com | 3% |
Research ServicesNorth Carolina, United States11-50 Employees
Grifols Therapeutics, Inc. is a research company based out of 79 TW ALEXANDER DR 4101 RESEARCH COMMONS, Research Triangle Park, North Carolina, United States.
Grifols Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M
Grifols Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M